Literature DB >> 21752923

Hepatitis C virus infection is blocked by HMGB1 released from virus-infected cells.

Jong Ha Jung1, Ji Hoon Park, Min Hyeok Jee, Sun Ju Keum, Min-Sun Cho, Seung Kew Yoon, Sung Key Jang.   

Abstract

High-mobility group box 1 (HMGB1), an abundant nuclear protein that triggers host immune responses, is an endogenous danger signal involved in the pathogenesis of various infectious agents. However, its role in hepatitis C virus (HCV) infection is not known. Here, we show that HMGB1 protein is translocated from the nucleus to cytoplasm and subsequently is released into the extracellular milieu by HCV infection. Secreted HMGB1 triggers antiviral responses and blocks HCV infection, a mechanism that may limit HCV propagation in HCV patients. Secreted HMGB1 also may have a role in liver cirrhosis, which is a common comorbidity in HCV patients. Further investigations into the roles of HMGB1 in the diseases caused by HCV infection will shed light on and potentially help prevent these serious and prevalent HCV-related diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21752923      PMCID: PMC3165778          DOI: 10.1128/JVI.00682-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose.

Authors:  J J H Chu; M L Ng
Journal:  J Gen Virol       Date:  2003-12       Impact factor: 3.891

Review 2.  Kinetics of the immune response during HBV and HCV infection.

Authors:  Antonio Bertoletti; Carlo Ferrari
Journal:  Hepatology       Date:  2003-07       Impact factor: 17.425

3.  Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production.

Authors:  Masaaki Korenaga; Ting Wang; Yanchun Li; Lori A Showalter; Tehsheng Chan; Jiaren Sun; Steven A Weinman
Journal:  J Biol Chem       Date:  2005-09-08       Impact factor: 5.157

Review 4.  HMGB1 as a DNA-binding cytokine.

Authors:  Ulf Andersson; Helena Erlandsson-Harris; Huan Yang; Kevin J Tracey
Journal:  J Leukoc Biol       Date:  2002-12       Impact factor: 4.962

5.  Modification of a PCR-based site-directed mutagenesis method.

Authors:  C L Fisher; G K Pei
Journal:  Biotechniques       Date:  1997-10       Impact factor: 1.993

Review 6.  Course and outcome of hepatitis C.

Authors:  Jay H Hoofnagle
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 7.  Natural history of chronic hepatitis C.

Authors:  Leonard B Seeff
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 8.  Hepatitis C virus and the immune system: a concise review.

Authors:  Christel Gremion; Andreas Cerny
Journal:  Rev Med Virol       Date:  2005 Jul-Aug       Impact factor: 6.989

Review 9.  Safety of interferon beta treatment for chronic HCV hepatitis.

Authors:  D Festi; L Sandri; G Mazzella; E Roda; T Sacco; T Staniscia; S Capodicasa; A Vestito; A Colecchia
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

10.  Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner.

Authors:  Jong Heon Kim; Ki Young Paek; Kobong Choi; Tae-Don Kim; Bumsuk Hahm; Kyong-Tai Kim; Sung Key Jang
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

View more
  29 in total

1.  PCV2 Induces Reactive Oxygen Species To Promote Nucleocytoplasmic Translocation of the Viral DNA Binding Protein HMGB1 To Enhance Its Replication.

Authors:  Renjie Sun; Siqi Sun; Yikai Zhang; Yingshan Zhou; Ying Shan; Xiaoliang Li; Weihuan Fang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Respiratory Syncytial Virus Infection Triggers Epithelial HMGB1 Release as a Damage-Associated Molecular Pattern Promoting a Monocytic Inflammatory Response.

Authors:  Yashoda M Hosakote; Allan R Brasier; Antonella Casola; Roberto P Garofalo; Alexander Kurosky
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

3.  High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.

Authors:  Wei Yan; Ying Chang; Xiaoyan Liang; Jon S Cardinal; Hai Huang; Stephen H Thorne; Satdarshan P S Monga; David A Geller; Michael T Lotze; Allan Tsung
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

4.  Proinflammatory Effects of Respiratory Syncytial Virus-Induced Epithelial HMGB1 on Human Innate Immune Cell Activation.

Authors:  Kempaiah Rayavara; Alexander Kurosky; Susan J Stafford; Nisha J Garg; Allan R Brasier; Roberto P Garofalo; Yashoda M Hosakote
Journal:  J Immunol       Date:  2018-10-01       Impact factor: 5.422

5.  Released Tryptophanyl-tRNA Synthetase Stimulates Innate Immune Responses against Viral Infection.

Authors:  Hyun-Cheol Lee; Eun-Seo Lee; Md Bashir Uddin; Tae-Hwan Kim; Jae-Hoon Kim; Kiramage Chathuranga; W A Gayan Chathuranga; Mirim Jin; Sunghoon Kim; Chul-Joong Kim; Jong-Soo Lee
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

6.  HMGB1 Promotes Hepatitis C Virus Replication by Interaction with Stem-Loop 4 in the Viral 5' Untranslated Region.

Authors:  Rong Yu; Darong Yang; Shaohua Lei; Xiaohong Wang; Xianghe Meng; Binbin Xue; Haizhen Zhu
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

7.  Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer.

Authors:  Assia L Angelova; Svitlana P Grekova; Anette Heller; Olga Kuhlmann; Esther Soyka; Thomas Giese; Marc Aprahamian; Gaétan Bour; Sven Rüffer; Celina Cziepluch; Laurent Daeffler; Jean Rommelaere; Jens Werner; Zahari Raykov; Nathalia A Giese
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

8.  Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in β-cells.

Authors:  R Guzmán-Ruiz; F Ortega; A Rodríguez; R Vázquez-Martínez; A Díaz-Ruiz; S Garcia-Navarro; M Giralt; A Garcia-Rios; D Cobo-Padilla; F J Tinahones; J López-Miranda; F Villarroya; G Frühbeck; J M Fernández-Real; M M Malagón
Journal:  Int J Obes (Lond)       Date:  2014-02-28       Impact factor: 5.095

Review 9.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 10.  Emerging role of high-mobility group box 1 (HMGB1) in liver diseases.

Authors:  Ruochan Chen; Wen Hou; Qiuhong Zhang; Rui Kang; Xue-Gong Fan; Daolin Tang
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.